Page last updated: 2024-08-23

fenoxaprop ethyl and Cancer of Stomach

fenoxaprop ethyl has been researched along with Cancer of Stomach in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Cao, Q; Chen, Y; Hong, Q; Lin, S; Liu, X; Sun, J	1

Other Studies

1 other study(ies) available for fenoxaprop ethyl and Cancer of Stomach

Article	Year
Knockdown of CALM2 increases the sensitivity to afatinib in HER2-amplified gastric cancer cells by regulating the Akt/FoxO3a/Puma axis. Toxicology in vitro : an international journal published in association with BIBRA, 2023, Volume: 87 Topics: Afatinib; Animals; Apoptosis; Calmodulin; Cell Line, Tumor; Drug Resistance, Neoplasm; Forkhead Box Protein O3; Humans; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Puma; Stomach Neoplasms	2023

Article

Year

Knockdown of CALM2 increases the sensitivity to afatinib in HER2-amplified gastric cancer cells by regulating the Akt/FoxO3a/Puma axis.

Toxicology in vitro : an international journal published in association with BIBRA, 2023, Volume: 87

Topics: Afatinib; Animals; Apoptosis; Calmodulin; Cell Line, Tumor; Drug Resistance, Neoplasm; Forkhead Box Protein O3; Humans; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Puma; Stomach Neoplasms

2023